Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
03/2000
03/16/2000DE19845434C1 Tissue binding peptides and related nucleotide sequences useful for tissue specific gene transfer
03/16/2000CA2343136A1 Diagnostic method for detecting disturbances of the pancreas
03/15/2000EP0984982A1 Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
03/15/2000EP0769956B1 USE OF A GnRH ANTAGONIST FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GONADAL-STEROID CONDITIONS
03/15/2000EP0656008B1 Thrombin receptor antagonists
03/15/2000EP0641358B1 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR
03/15/2000EP0541726B1 Growth factor compositions, preparation and use
03/15/2000CN1247543A Cyclic peptide derivatives
03/14/2000US6037320 Neurotrophic factor (NT-4)
03/14/2000US6037165 Methods for the preparation of human immunodeficiency virus type 2 (HIV-2) and antigens encoped thereby
03/14/2000US6037137 Fluorogenic peptides for the detection of protease activity
03/14/2000CA2143335C Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof
03/14/2000CA1340926C Human rhinovirus peptides
03/09/2000WO2000012709A2 Phelix: a testis-specific protein expressed in cancer
03/09/2000WO2000012706A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
03/09/2000WO2000012587A2 Polyamide chains of precise length, methods to manufacture them and their conjugates
03/09/2000WO2000012553A1 Cyclic prosaposin-derived peptides and uses thereof
03/09/2000WO2000012540A1 Reversible boronate complexes of 1,2-cis-diol cyclic-peptides
03/09/2000WO2000012538A1 Triple helix coil template having a biologically active ligand
03/09/2000WO2000012524A1 Purification of oligomers using dual-end selection
03/09/2000DE19845251A1 Peptide für Pharmatargeting Peptides for drug targeting
03/09/2000CA2351739A1 Polyamide chains of precise length, methods to manufacture them and their conjugates with proteins
03/09/2000CA2341810A1 Cyclic prosaposin-derived peptides and uses thereof
03/09/2000CA2340647A1 Reversible boronate complexes of 1,2-cis-diol cyclic-peptides
03/09/2000CA2340592A1 Phelix: a testis-specific protein expressed in cancer
03/08/2000EP0983346A2 Short peptides which selectively modulate the activity of serine/threonine kinases
03/08/2000EP0983300A1 Bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
03/08/2000EP0983297A1 New echinocandine derivatives with antimicrobial activity
03/08/2000EP0835125A4 Cd4-derived peptides that inhibit immune responses
03/07/2000US6034216 Low molecular weight peptidomimetic growth hormone secretagogues
03/07/2000US6034066 Cysteine protease inhibitors for use in treatment of IGE mediated allergic diseases
03/07/2000US6034064 Polypeptide
03/07/2000US6034058 Administering polypeptide
03/07/2000US6034057 Cyclic octapeptide; antiarthritic agent
03/07/2000US6034056 Cyclic peptides; antiarthritic agents
03/07/2000US6033884 Delivering nucleic acid into a cell.
03/07/2000US6033654 Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer
03/02/2000WO2000011179A1 RECOMBINANT MULTIVALENT MALARIAL VACCINE AGAINST $i(PLASMODIUM FALCIPARUM)
03/02/2000WO2000011032A2 Method for producing biostatin (tt-232 triacetate) and analogs thereof
03/02/2000WO2000011031A1 Method for producing biostatin (tt-232 triacetate) and the analogs thereof
03/02/2000WO2000011029A2 Novel anti-diabetic peptides
03/02/2000WO2000011028A2 Anti-inflammatory peptides derived from il-2 and analogues thereof
03/02/2000WO2000011023A2 Ring modified cyclic peptide analogs
03/02/2000WO2000011022A1 Anti-cancer compounds and methods related thereto
03/02/2000WO2000011020A1 Deoxyhypusine reagent and peptides
03/02/2000WO2000010591A1 Peptides for inhibition of herpes simplex virus entry
03/02/2000WO1999065506A3 Cancer therapy with indolicidin or cationic peptides and their polymer conjugates
03/02/2000DE19941248A1 New cetrorelix analogs containing N-substituted glycine derivatives useful as LHRH antagonists, e.g. for treating hormone-dependent tumors
03/02/2000CA2340676A1 Ring modified cyclic peptide analogs
03/02/2000CA2306456A1 Deoxyhypusine reagent and peptides
03/01/2000EP0981541A1 Psca: prostate stem cell antigen
03/01/2000EP0981540A1 A NOVEL STRAIN OF $i(BACILLUS) FOR CONTROLLING PLANT DISEASES AND CORN ROOTWORM
03/01/2000EP0981539A1 Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the c-terminus
03/01/2000EP0981364A1 Method and compositions for treating hyperlipidemia and other conditions
03/01/2000EP0981358A1 Dolastatin-15 derivatives in combination with taxanes
03/01/2000EP0618926B1 New peptide derivatives
03/01/2000CN1246126A Antimicrobially active polypeptides
03/01/2000CN1246125A Peptides comprising a T-cell epitope specific to collagen II
03/01/2000CN1246059A Polymers
02/2000
02/29/2000US6031073 Cyclic polypeptides comprising a thioether linkage and methods for their preparation
02/29/2000US6031072 Compounds and methods for modulating cell adhesion
02/29/2000US6031071 Oligopeptide of a generic amino acid sequence having a tryptophan or phenylalanine at a specific site; capable of binding molecules or their natural receptor; for agonists or antagonists
02/29/2000US6030944 Cyclohexapeptidyl bisamine compounds
02/29/2000US6030835 Methods and composition for identifying group a streptococcus
02/29/2000US6030640 Oligoglycine compound, fibrous microtube of oligoglycine compound and process of producing fibrous microtube
02/29/2000CA1340914C Oligopeptides and their use for diagnostic and vaccination purposes for aids and arc
02/24/2000WO2000009735A1 A cyclic lipopeptide from cryptosporiopsis quercina possessing antifungal activity
02/24/2000WO2000009711A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)
02/24/2000WO2000009558A1 Hepatitis c inhibitor peptides
02/24/2000WO2000009553A2 Antimicrobial peptides isolated from the skin of american frogs
02/24/2000WO2000009546A1 Process for the preparation of regular glycopeptides
02/24/2000WO2000009545A1 Pentapeptide lhrh analogs
02/24/2000WO2000009544A1 Heptapeptide lhrh analogs
02/24/2000WO2000009537A2 Compounds having growth hormone releasing activity
02/24/2000WO2000009149A1 Tnf-derived peptides for use in treating oedema
02/24/2000WO2000009144A1 Methods to increase blood flow to ischemic tissue
02/24/2000WO2000009143A1 Multivalent avb3 and metastasis-associated receptor ligands
02/24/2000WO2000002905A3 Methods for accelerating bone and cartilage growth and repair
02/24/2000WO1999064050A8 Novel potassium channel drugs and their uses
02/24/2000DE19837015A1 New human soluble guanylate cyclase alpha1/beta1 and the nucleic acid encoding the subunits, useful for producing diagnostic antibodies, and for somatic gene therapy of arteriosclerosis
02/24/2000CA2339330A1 Methods to increase blood flow to ischemic tissue
02/24/2000CA2338885A1 Antimicrobial peptides isolated from the skin of american frogs
02/24/2000CA2338283A1 Multivalent avb3 and metastasis-associated receptor ligands
02/23/2000EP0980526A1 Inhibitors of nuclear protein/nuclear receptor interaction
02/23/2000EP0980440A1 Fluorogenic protease substrates based on dye-dimerization
02/23/2000EP0980385A1 Peptides and compounds that bind to the il-5 receptor
02/23/2000EP0980240A1 Sustained-release compositions and method for preparing same
02/23/2000CN1245504A Peptides and compounds that bind to receptor
02/23/2000CN1049686C Diagnostics and vaccines for hepatits virus non-A and non-B
02/22/2000US6028168 Lanthionine bridged peptides
02/22/2000US6027711 Structurally determined metallo-constructs and applications
02/22/2000CA1340911C Antiherpes cyclic peptides
02/22/2000CA1340910C Fibronectin binding protein
02/22/2000CA1340907C Synthetic antigen evoking anti-hiv responese
02/17/2000WO2000008197A1 Method for the production of an antibiotic agent
02/17/2000WO2000008049A1 Cyclic peptides with antagonistic activity specific for bradykinin b2 receptor and formulations containing them
02/17/2000WO2000008046A1 Monocyclic compounds having nk-2 antagonist action and compositions containing them
02/17/2000WO2000008033A1 Water soluble prodrugs of hindered alcohols or phenols
02/17/2000WO2000007609A1 Peptide antagonists of zonulin and methods for use of the same
02/17/2000WO1999065942A8 Cyclic somatostatin analogs